Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANVS | NVCT | EPRX | ||
| Company | Annovis Bio Inc | Nuvectis Pharma Inc | Eupraxia Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 6.85 | 4.94 | 3.49 | ||
| High | 6.95 | 4.97 | 3.49 | ||
| Low | 6.72 | 4.61 | 3.27 | ||
| Last | 6.90 | 4.71 | 3.35 | ||
| Change | +0.11 | -0.19 | -0.02 | ||
| % Change | +1.62% | -3.88% | -0.74% | ||
| Volume | 53,872 | 65,929 | 9,109 | ||
| 20-Day Average Volume | 210,929 | 305,078 | 33,710 | ||
| Previous Close | 6.79 | 4.90 | 3.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 7.99 | 7.33 | 3.04 | ||
| 20-Day Raw Stochastic | 9.90% | 1.45% | 58.10% | ||
| 20-Day Relative Strength | 37.44% | 38.11% | 59.47% | ||
| Weighted Alpha | -25.45 | -36.52 | +6.55 | ||
| Today's Opinion | 88% Sell | 24% Sell | 56% Buy | ||
| Previous Opinion | 88% Sell | 24% Sell | 56% Buy | ||
| Last Month's Opinion | 24% Sell | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.88% since 11/15/24 | -4.75% since 11/15/24 | +6.85% since 11/15/24 | ||
| Low | 6.37 on 11/21/24 | 4.61 on 11/22/24 | 3.05 on 11/19/24 | ||
| High | 6.97 on 11/18/24 | 5.49 on 11/19/24 | 4.08 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | -29.60% since 10/22/24 | -41.57% since 10/22/24 | +38.80% since 10/22/24 | ||
| Low | 6.37 on 11/21/24 | 4.61 on 11/22/24 | 2.33 on 10/25/24 | ||
| High | 10.54 on 10/28/24 | 11.80 on 11/12/24 | 4.08 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | -26.22% since 08/22/24 | -34.51% since 08/22/24 | +28.65% since 08/22/24 | ||
| Low | 6.37 on 11/21/24 | 4.61 on 11/22/24 | 2.20 on 10/14/24 | ||
| High | 10.54 on 10/28/24 | 11.80 on 11/12/24 | 4.08 on 11/20/24 | ||
| 6-Month | |||||
| %Chg | -11.37% since 05/22/24 | -29.31% since 05/22/24 | +13.39% since 05/22/24 | ||
| Low | 4.53 on 07/02/24 | 4.61 on 11/22/24 | 2.20 on 10/14/24 | ||
| High | 17.88 on 07/09/24 | 11.80 on 11/12/24 | 4.08 on 11/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 93,682 | 94,673 | 91,940 | ||
| Shares Outstanding, K | 13,797 | 19,321 | 27,282 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -56,200,000 | -22,260,000 | -28,220,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -12,640,000 | -4,150,000 | -5,940,000 | ||
| 60-Month Beta | 1.70 | 0.41 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 11/08/24 | -0.24 on 11/05/24 | -0.17 on 11/07/24 | ||
| Latest Earnings Date | 11/13/24 | 11/13/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||